Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
Tickers BMY BNTX PFE REGN
Tags Recent Press Releases PFE REGN
From Motley Fool
PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
Tickers PTCT RHHBY RPRX SPX
Tags RHHBY PTCT SPX
From MarketWatch
Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products
Tickers RHHBF RHHBY RHHVF
Tags Biotech Benzinga Briefs
From Benzinga
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
Tickers GLUE RHHBF RHHBY RHHVF
Tags Large Cap News Health Care
From Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
Tickers AZN BMY MRK RHHBY
Tags Briefs Biotech Benzinga
From Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
Tickers BMY NVO PRTA RHHBY
Tags M&A Market News BMY
From Benzinga
Tempest Therapeutics shares head back to earth after 4,000% gain
Tickers RHHBY SPX TPST
Tags RHHBY TPST SPX
From MarketWatch
TPST Stock: 7 Things to Know About Tempest Therapeutics
Tickers RHHBY TPST
Tags Today's Market RHHBY TPST
From InvestorPlace
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
Tickers BIIB DGX ESALY LH
Tags RHHBY BIIB Market News
From Benzinga
Tempest Therapeutics’ stock jumps 1,900% as liver-cancer treatment shows promise
Tickers RHHBY SPX TPST
Tags SPX RHHBY TPST
From MarketWatch
Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update
Tickers RHHBY SNY TLSA
Tags RHHBY TLSA General
From Benzinga
Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich
Tickers CRSP MRNA PSTX RHHBY
Tags RHHBY PSTX Stocks to Buy
From InvestorPlace
2 Cathie Wood Stocks That Could Deliver Exponential Returns
Tickers ARKK EXAS NVDA RHHBY
Tags Recent Press Releases ARKK RXRX
From Motley Fool
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
Tickers ALNY AZN IONS NVS
Tags RHHBY Contracts AZN
From Benzinga
AI To Revolutionize Clinical Trials And Diagnostics
Tickers AMGN BAYRY MYNZ NVS
Tags RHHBY Market News NVS
From Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
Tickers A ABT BDX BRKR
Tags RAD PKI News
From Benzinga
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
Tickers ALNY ARKG BBIO RHHBY
Tags Market News NYSEARCA:ARKG;NYSEARCA:XBI;NASDAQ:ALNY;OTCMKTS:RHHBY;NASDAQ:BBIO BBIO
From InvestorPlace
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
Tickers BLUE RHHBY RXRX
Tags RHHBY Market News BAYR/Y
From Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
Tickers ILMN JNJ ME NVS
Tags Small Cap General PFE
From Benzinga
Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data
Tickers NVDA RHHBY RXRX
Tags RHHBY NVDA RXRX
From MarketWatch
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
Tickers ALNY IONS RHHBF RHHBY
Tags Benzinga Biotech Expert Ideas
From Benzinga
Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Biotech Health Care Benzinga
From Benzinga
Cancer Treatment In 7 Minutes: UK's Health Service To Rollout Roche's Tencentriq Injection Cutting Treatment Time
Tickers RHHBF RHHBY RHHVF
Tags Large Cap News Health Care
From Benzinga
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
Tickers ADPT AMLX ARKG IOVA
Tags NASDAQ:IOVA,NASDAQ:AMLX,NASDAQ:ADPT,OTCMKTS:RHHBY,BATS:ARKG ADPT AMLX
From InvestorPlace
Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update
Tickers BGNE GILD ITOS MRK
Tags Health Care Large Cap News
From Benzinga
Roche's Accidental Lung Cancer Trial Data Leak: Shows Encouraging Early Data From Combination Therapy Study
Tickers RHHBF RHHBY RHHVF
Tags General RHHVF RHHBF
From Benzinga
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
Tickers REGN RHHBY
Tags News Large Cap Trading Ideas
From Benzinga
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
Tickers EXEL IPSEF IPSEY RHHBF
Tags RHHVF General IPSEF
From Benzinga
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
Tickers BAYN NTLA REGN RHHBY
Tags REGN SNY Recent Press Releases
From Motley Fool
What's Going On With Sonnet BioTherapeutics Stock Today?
Tickers RHHBY SONN
Tags Briefs Movers Biotech
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.